OnCo
ideasIdea

Personalised stool-test cut-offs by age, sex and prior results

Bowel screening uses one blood-in-stool threshold for everyone. Setting it by age, sex and the person's previous results would find more cancers with the same number of colonoscopies.

FIT haemoglobin concentration and prior FIT values strongly predict future advanced neoplasia. Propose risk-adapted FIT thresholds and intervals (low prior FIT to three-yearly; high sub-threshold FIT to recall in one year), tested within a national programme.

Hypothesis
Risk-adapted FIT increases advanced neoplasia detected per colonoscopy by at least 20% and reduces interval cancers by at least 15% at constant colonoscopy capacity.
Rationale
Colonoscopy capacity, not FIT cost, is the binding constraint; modelling from the Dutch and Scottish programmes supports it.
What would test it
Randomised evaluation within a national programme (e.g. the Netherlands) with a four-year endpoint.
Maturity
early clinical
Who has to act
policy
Cost to try
Small (under $1M)
Years to first evidence
4
Bottlenecks it attacks
  • Most lethal cancers are found late · Screening exists for only a few cancers. Pancreatic, ovarian, liver, oesophageal and most lung cancers are found when cure is unlikely.
  • Overdiagnosis and false alarms · Finding more cancer is not the same as saving lives. Screening also finds cancers that would never have hurt anyone, and treats them.

Key papers

2top

Connected

6top